Advances in the Assessment and Management of Multiple Sclerosis; At the conclusion of this activity, participants will be able to:
Assess and apply recent clinical guidelines, emerging evidence, and current expert opinion to improve the differential diagnosis of multiple sclerosis (MS);
Choose among currently approved disease-modifying therapies for MS patients based on patient characteristics and recent clinical evidence, and outline the potential role of novel therapies currently in development;
Understand the significance and utility of emerging diagnostic and prognostic biomarkers for MS in order to appropriately apply them in clinical practice;
Identify common reasons for suboptimal patient adherence to disease-modifying therapies and apply strategies to improve adherence to treatment;
Develop evidence-based, expert-driven management plans for MS symptoms that improve functional abilities and quality of life for patients with MS.
The summit is planned to meet the continuing medical education needs of neurologists involved in the diagnosis, treatment and ongoing management of patients with MS. Additionally, general neurologists, internists, family physicians, nurse practitioners, physician assistants, and pharmacists who are actively engaged in the care of patients with MS may also benefit from participating in the program as secondary audiences.
The Northwestern University Feinberg School of Medicine designates this enduring material for a maximum of 6.0 AMA PRA Category 1 Credit(s)™.
American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit™ .
American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 Credit™ .
American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™. No fee.
Visit the website
Please send all inquiries to: Northwestern University Feinberg School of Medicine, Office of Continuing Medical Education, by phone: 312-503-8533 or email: email@example.com